Marksans Pharma Shareholding

Marksans Pharma Ltd Shareholding Pattern

The Marksans Pharma Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Marksans Pharma Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Marksans Pharma Ltd (NSE: MARKSANS, BSE: 524404) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Marksans Pharma Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Marksans Pharma Ltd Shareholding Pattern (Latest)

The latest Marksans Pharma Ltd shareholding for Dec 2025 is:

• Promoters: 43.87%
• FII: 8.12%
• DII: 5.91%
• Public: 42.09%
• Government: 0%

Promoter holding in Marksans Pharma Ltd remains stable, reflecting consistent long-term commitment.

Marksans Pharma Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Marksans Pharma Ltd.

• Dec 2025: 43.87%
• Sept 2025: 43.87%
• Jun 2025: 43.87%
• Mar 2025: 43.87%
• Dec 2024: 43.87%

Promoter stake remains largely stable, showing consistent ownership structure.

Marksans Pharma Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Marksans Pharma Ltd.

• Dec 2025: 8.12%
• Sept 2025: 16.92%
• Jun 2025: 19.88%
• Mar 2025: 22.20%
• Dec 2024: 21.96%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Marksans Pharma Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Dec 2025: 5.91%
• Sept 2025: 5.28%
• Jun 2025: 5.50%
• Mar 2025: 4.56%
• Dec 2024: 4.30%

DII stake in Marksans Pharma Ltd has increased over time, indicating growing domestic institutional confidence.

Marksans Pharma Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Dec 2025: 42.09%
• Sept 2025: 33.93%
• Jun 2025: 30.75%
• Mar 2025: 29.37%
• Dec 2024: 29.87%

Public participation in Marksans Pharma Ltd has increased, indicating rising retail investor interest.

Marksans Pharma Ltd Government Holding

Government holding in Marksans Pharma Ltd currently stands at 0%.

Marksans Pharma Ltd operates without significant government ownership.

Marksans Pharma Ltd Shareholding Analysis Summary

The Marksans Pharma Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Marksans Pharma Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Marksans Pharma Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.